Innovent Biologics has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for ...

The DaRe2THINK platform – developed by the University of Birmingham and the MHRA's Clinical Practice Research Datalink (CPRD) ...

The federal government shutdown meant that the Securities & Exchange Commission (SEC), which oversees listing processes in ...

Radiopharmaceutical innovator AdvanCell has appointed Andrew Kay as Chair of the Board. Kay previously served as CEO of ...

In a new pharmaphorum podcast, web editor Nicole Raleigh is joined by Piet van der Graaf, Senior VP at Certara – a company ...

The NHS’s Online Hospital ambition signals intent. But to make it real, the focus must move from building a digital replica ...

A clinical trial of Vaderis Therapeutics' AKT inhibitor engasertib suggests it could be the first effective treatment for ...

UK researchers have developed a platform that can test whether commercial AI algorithms developed for NHS applications are ...

Direct-to-Patient (DTP) platforms represent a new frontier in patient support services. Properly executed, they help more ...

Donor plasma samples contain information that could lead to massive advances in disease prevention. pharmaphorum grabbed a ...

Rob Milnes (Ultrahuman) connected with pharmaphorum off the Frontiers Health stage to share some insights, following a ...

Progress in the treatment of T-cell blood cancers – which are rare – has also been modest. So, much remains to be done to ...